Details for New Drug Application (NDA): 050581

NDA 050581 describes MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for 050581

Tradename:	MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:	Merck
Ingredient:	cefoxitin sodium
Patents:	0

Medical Subject Heading (MeSH) Categories for 050581

Anti-Bacterial Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Sep 20, 1984	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Sep 20, 1984	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Sep 20, 1984	TE:		RLD:	Yes

Complete Access Available with Subscription